Inventor · disambiguated record
Wayne Vaccaro
Also filed as: VACCARO WAYNE · VACCARO WAYNE D · VACCARO WAYNE DAVID
42 granted patents·9 pending applications·1,490 citations·filing 1990–2022
98Inventor score
Top patents by PatentIndex Score
51 records- 0198US5883096AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 16, 1999·164 cites·17 claims
- 0297US5656624A4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agentsSCHERING CORP·Filed 1994·Granted Aug 12, 1997·115 cites·3 claims
- 0396US7723336B2Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 25, 2010·50 cites·16 claims
- 0496US7439246B2Fused heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 21, 2008·30 cites·31 claims
- 0596US6511977B1Potassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jan 28, 2003·46 cites·11 claims
- 0696US6150356APotassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Nov 21, 2000·73 cites·14 claims
- 0796US6037352AMuscarinic antagonistsSCHERING CORP·Filed 1998·Granted Mar 14, 2000·90 cites·11 claims
- 0895US7157451B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 2, 2007·70 cites·15 claims
- 0995US6838559B2Purine inhibitors of phosphodiesterase (PDE) 7BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 4, 2005·79 cites·1 claims
- 1095US5688787ASubstituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereofSCHERING CORP·Filed 1996·Granted Nov 18, 1997·90 cites·7 claims
- 1194US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 1294US6706720B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Mar 16, 2004·60 cites·21 claims
- 1393US5889006AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 30, 1999·123 cites·18 claims
- 1493US5688785ASubstituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1995·Granted Nov 18, 1997·69 cites·6 claims
- 1591US7173031B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 6, 2007·25 cites·18 claims
- 1690US6288068B1Muscarinic antagonistsSCHERING CORP·Filed 2000·Granted Sep 11, 2001·22 cites·5 claims
- 1786US5756470ASugar-substituted 2-azetidinones useful as hypocholesterolemic agentsSCHERING CORP·Filed 1996·Granted May 26, 1998·154 cites·20 claims
- 1885US6995181B2Modulators of the glucocorticoid receptor and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·23 cites·28 claims
- 1985US6881753B2Potassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 19, 2005·10 cites·7 claims
- 2084US7253283B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 7, 2007·6 cites·15 claims
- 2183US7235543B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2004·Granted Jun 26, 2007·13 cites·21 claims
- 2282US6043255AMuscarinic antagonistsSCHERING CORP·Filed 1999·Granted Mar 28, 2000·50 cites·16 claims
- 2379US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 2479US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 2579US6100279AImidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atomSCHERING CORP·Filed 1998·Granted Aug 8, 2000·53 cites·23 claims
- 2678US10053454B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 21, 2018·3 cites·5 claims
- 2777US7923556B2Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 12, 2011·2 cites·10 claims
- 2877US6784189B2Potassium channel inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 31, 2004·5 cites·11 claims
- 2975US9725449B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 8, 2017·2 cites·17 claims
- 3075US5149709AInhibitors of acyl-coenzyme A: cholesterol acyl transferaseSCHERING CORP·Filed 1990·Granted Sep 22, 1992·11 cites·16 claims
- 3174US9751879B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 5, 2017·1 cites·13 claims
- 3274US7541362B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 2, 2009·1 cites·8 claims
- 3374US6498168B2Muscarinic antagonistsSCHERING CORP·Filed 2001·Granted Dec 24, 2002·5 cites·5 claims
- 3469US8389527B2Substituted imidazopyridazines useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Mar 5, 2013·1 cites·12 claims
- 3565US7741289B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2008·Granted Jun 22, 2010·0 cites·20 claims
- 3661US7368563B2Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereofSCHERING CORP·Filed 2007·Granted May 6, 2008·0 cites·22 claims
- 3758US2024217982A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3858US2024317769A1Kras g12d inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3956US7544808B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 9, 2009·0 cites·14 claims
- 4053US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4150US5326762AInhibitors of acyl-coenzyme A: cholesterol acyl transferaseSCHERING CORP·Filed 1992·Granted Jul 5, 1994·3 cites·10 claims
- 4249US2006178388A1Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsWROBLESKI STEPHEN T·Filed 2006·Application pending·0 cites
- 4349US2005171136A1Modulators of the glucocorticoid receptor and methodFiled 2005·Application pending·0 cites
- 4448US10196387B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·0 cites·5 claims
- 4548US7968577B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 28, 2011·0 cites·16 claims
- 4646US2016318928A1Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 4745US5416118ABicyclic amides as inhibitors of acyl-coenzyme A: cholesterol acyl transferaseSCHERING CORP·Filed 1992·Granted May 16, 1995·3 cites·12 claims
- 4845US2007078136A1Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 4944US2004024001A1Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteasesFiled 2003·Application pending·0 cites
- 5043US2010204212A1Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wayne Vaccaro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →